Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
1.265
-0.125 (-8.99%)
Apr 1, 2025, 4:00 PM EDT - Market closed

Taysha Gene Therapies Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Net Income
-89.3-111.57-166.01-174.52-60.01
Upgrade
Depreciation & Amortization
1.251.371.170.490.01
Upgrade
Other Amortization
-0.87---
Upgrade
Asset Writedown & Restructuring Costs
4.844.5737.679.759
Upgrade
Stock-Based Compensation
13.17.9118.0418.183.35
Upgrade
Other Operating Activities
1.3541.852.220.3917.03
Upgrade
Change in Accounts Payable
-2.92-2.3-7.814.491.96
Upgrade
Change in Unearned Revenue
-8.33-15.4533.56--
Upgrade
Change in Other Net Operating Assets
-1.21-0.27-7.2414.17-2.07
Upgrade
Operating Cash Flow
-81.23-73.02-88.39-117.04-30.73
Upgrade
Capital Expenditures
-0.37-3.87-20.62-15.3-0.08
Upgrade
Sale (Purchase) of Intangibles
--3.5-4.25-6.25-9
Upgrade
Other Investing Activities
0.010.02-0.06--
Upgrade
Investing Cash Flow
-0.36-7.35-24.93-21.55-9.08
Upgrade
Short-Term Debt Issued
----1.67
Upgrade
Long-Term Debt Issued
-39.55-39.96-
Upgrade
Total Debt Issued
-39.55-39.961.67
Upgrade
Short-Term Debt Repaid
-----1.67
Upgrade
Long-Term Debt Repaid
--43---
Upgrade
Total Debt Repaid
--43---1.67
Upgrade
Net Debt Issued (Repaid)
--3.45-39.96-
Upgrade
Issuance of Common Stock
76.87140.8653.5-165.85
Upgrade
Other Financing Activities
-0.19-1.02-1.4-0.87-0.79
Upgrade
Financing Cash Flow
76.68136.3952.139.08291.06
Upgrade
Net Cash Flow
-4.956.02-61.22-99.51251.25
Upgrade
Free Cash Flow
-81.6-76.89-109.01-132.35-30.81
Upgrade
Free Cash Flow Margin
-979.23%-497.62%-4356.88%--
Upgrade
Free Cash Flow Per Share
-0.33-0.66-2.48-3.52-1.74
Upgrade
Cash Interest Paid
5.284.952.780.640.03
Upgrade
Levered Free Cash Flow
-48.15-68.51-75.31-71.32-32.24
Upgrade
Unlevered Free Cash Flow
-48.09-66.25-72.94-70.43-32.23
Upgrade
Change in Net Working Capital
7.9323.55-11.49-40.74-0.37
Upgrade
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q